The company is developing a prototype of an innovative pharmaceutical, based on carcinolytic strains of the Newcastle disease (NDV), isolated from natural reservoirs in the territory of RF.
In the course of the project implementation, the first in Russia collection of NDV strains will be formed, and description of the structural mechanisms of the lytic mechanisms of the NDV on tumor cells, which will significantly enrich the available molecular-biological and immunological data.
The pharmaceutical to be obtained will be used not only for treatment of patients but also as a preventive remedy to eliminate cancer at early stages, when diagnostics of the disease is unlikely.
1 Tecnoparkovaya Str., Koltsovo town, Novosibirsk region, 630559, Russia, suite 215
Deputy director for economic issues: Vladimir Arkadyevich Zabelin
+7 (383) 381-45-13